Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Kisspeptin Protocol Comparison — Dosing Strategies and Outcomes

| Protocol Type | Dose | Frequency | Duration | LH Response | Expected Outcome | Bottom Line ||—|—|—|—|—|—|| Standard HPTA Restart | 100–250mcg | Once daily (morning) | 4–6 weeks | 3–5× baseline within 90 min | Restore endogenous testosterone production post-c

This comparison does not assign a generated winner or score.

  • | Protocol Type | Dose | Frequency | Duration | LH Response | Expected Outcome | Bottom Line ||—|—|—|—|—|—|| Standard HPTA Restart | 100–250mcg | Once daily (morning) | 4–6 weeks | 3–5× baseline within 90 min | Restore endogenous testosterone production post-cycle | Best for post-TRT recovery. Mimics natural pulsatile GnRH signalling || Aggressive Recovery | 250–500mcg | Once daily (morning) | 2–4 weeks | 5–10× baseline within 90 min | Faster LH elevation but higher receptor desensitisation risk | Use only if baseline LH <1.0 IU/L. Overkill for mild suppression || Sustained Output | 50–100mcg | Twice daily (morning/evening) | 4–6 weeks | Moderate elevation sustained 12+ hours | Maintain elevated testosterone levels throughout the day | Effective but requires strict timing. Missed doses disrupt pattern || Diagnostic Test | 1000mcg | Single dose | N/A | Evaluates HPTA responsiveness | Determines if hypothalamus/pituitary can respond to upstream signal | Not a treatment protocol. Used to
More references

Related material